Sequenom

San Diego, United States Founded: 1994 • Age: 32 yrs Acquired By LabCorp
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
Request Access

About Sequenom

Sequenom is a company based in San Diego (United States) founded in 1994 was acquired by LabCorp in July 2016.. Sequenom has completed 1 acquisition, including Sensigen. Sequenom offers products and services including Genetic Testing, At-Home Kits, and Clinical Trial Testing. Sequenom operates in a competitive market with competitors including Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.

  • Headquarter San Diego, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sequenom, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $85 M (USD), Debt – Conventional

    Jun 09, 2015

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    LabCorp

    (Jul 27, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sequenom

Sequenom offers a comprehensive portfolio of products and services, including Genetic Testing, At-Home Kits, and Clinical Trial Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for hereditary disease detection and analysis

Kits for self-collection and remote diagnostic testing

Testing support for biopharma and medical research

Funding Insights of Sequenom

  • Total Funding
  • Total Rounds 10
  • Last Round Debt – Conventional — $85.0M
  • First Round

    (01 Jan 2003)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2015 Amount Debt – Conventional - Sequenom Valuation

investors

May, 2010 Amount Post-IPO - Sequenom Valuation

investors

Dec, 2009 Amount Post-IPO - Sequenom Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sequenom

Sequenom has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provider of laboratory tests for physicians
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sequenom

Sequenom has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sensigen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Women's health and genetic testing services are provided with support.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Sequenom

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sequenom Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sequenom

Sequenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Provider of cell-free cancer liquid biopsy test
domain founded_year HQ Location
Non-invasive prenatal genomic testing is provided for genetic disorders.
domain founded_year HQ Location
Provider of medical diagnosis and clinical laboratory analysis services
domain founded_year HQ Location
NGS-based diagnostic solutions for neonatal screening are developed.
domain founded_year HQ Location
Non-invasive prenatal genetic tests and genomic services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sequenom

Frequently Asked Questions about Sequenom

When was Sequenom founded?

Sequenom was founded in 1994 and raised its 1st funding round 9 years after it was founded.

Where is Sequenom located?

Sequenom is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

What does Sequenom do?

Sequenom was established in 1994 in San Diego, United States, within the biotechnology sector. Noninvasive prenatal testing is delivered through circulating cell-free fetal nucleic acids. Laboratory-developed tests for prenatal diseases and conditions are developed and commercialized. Operations center on genetic diagnostics in healthcare, with services targeted at prenatal screening needs across the region.

Who are the top competitors of Sequenom?

Sequenom's top competitors include Natera, BillionToOne and Pictor.

What products or services does Sequenom offer?

Sequenom offers Genetic Testing, At-Home Kits, and Clinical Trial Testing.

How many acquisitions has Sequenom made?

Sequenom has made 1 acquisition, including Sensigen.

Who are Sequenom's investors?

Sequenom has 1 investor. Key investors include LabCorp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available